Eaton Vance Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-12,803
| Closed | -$930K | – | 1759 |
|
|
2022
Q1 | $930K | Buy |
12,803
+12,103
| +1,729% | +$879K | ﹤0.01% | 1380 |
|
|
2021
Q4 | $59K | Hold |
700
| – | – | ﹤0.01% | 2036 |
|
|
2021
Q3 | $63K | Hold |
700
| – | – | ﹤0.01% | 1496 |
|
|
2021
Q2 | $67K | Sell |
700
-75
| -10% | -$7.18K | ﹤0.01% | 2057 |
|
|
2021
Q1 | $88K | Buy |
+775
| New | +$88K | ﹤0.01% | 1639 |
|